@slavefire61
Active 8 hours, 21 minutes ago
BACKGROUND Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain. METHODS In a double-blind trial, patients with peripheral artery disease who had undergone […] View